PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 147 filers reported holding PLIANT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $817,598 | +220.8% | 47,151 | +235.2% | 0.19% | +91.8% |
| Q2 2023 | $254,876 | -58.1% | 14,066 | -38.5% | 0.10% | -70.7% |
| Q1 2023 | $608,395 | -20.2% | 22,872 | -42.0% | 0.33% | -13.1% |
| Q4 2022 | $761,969 | +60.8% | 39,419 | +73.7% | 0.38% | +128.1% |
| Q3 2022 | $474,000 | – | 22,697 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |